Visser PJ - Search Results

1

CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.

Tijms BM, Gobom J, Teunissen C, Dobricic V, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuévo JL, Engelborghs S, Freund-Levi Y, Froelich L, Bertram L, Lovestone S, Streffer J, Vos S, Adni, Blennow K, Scheltens P, Zetterberg H, Visser PJ. Tijms BM, et al. Among authors: visser pj. Proteomes. 2021 Aug 2;9(3):36. doi: 10.3390/proteomes9030036. Proteomes. 2021. PMID: 34449748 Free PMC article.

2

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer LJ, Jolles J, Jonker C. Visser PJ, et al. J Neurol. 1999 Jun;246(6):477-85. doi: 10.1007/s004150050387. J Neurol. 1999. PMID: 10431775

3

Distinction between preclinical Alzheimer's disease and depression.

Visser PJ, Verhey FR, Ponds RW, Kester A, Jolles J. Visser PJ, et al. J Am Geriatr Soc. 2000 May;48(5):479-84. doi: 10.1111/j.1532-5415.2000.tb04992.x. J Am Geriatr Soc. 2000. PMID: 10811539

4

Characteristics of preclinical Alzheimer's disease.

Visser PJ, Verhey FR, Ponds RW, Jolles J. Visser PJ, et al. Int J Geriatr Psychiatry. 2002 Jan;17(1):88-9. doi: 10.1002/gps.511. Int J Geriatr Psychiatry. 2002. PMID: 11802238 No abstract available.

5

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.

Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Visser PJ, et al. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7. doi: 10.1136/jnnp.72.4.491. J Neurol Neurosurg Psychiatry. 2002. PMID: 11909909 Free PMC article.

6

Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.

Visser PJ, Verhey FR, Scheltens P, Cruts M, Ponds RW, Van Broeckhoven CL, Jolles J. Visser PJ, et al. J Neurol. 2002 Mar;249(3):312-9. doi: 10.1007/s004150200011. J Neurol. 2002. PMID: 11993532 Clinical Trial.

7

Diagnosis of preclinical Alzheimer's disease in a clinical setting.

Visser PJ, Verhey FR, Ponds RW, Jolles J. Visser PJ, et al. Int Psychogeriatr. 2001 Dec;13(4):411-23. doi: 10.1017/s1041610201007839. Int Psychogeriatr. 2001. PMID: 12003248

8

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

Korf ES, Wahlund LO, Visser PJ, Scheltens P. Korf ES, et al. Among authors: visser pj. Neurology. 2004 Jul 13;63(1):94-100. doi: 10.1212/01.wnl.0000133114.92694.93. Neurology. 2004. PMID: 15249617

9

Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease.

Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, Barkhof F. Karas GB, et al. Among authors: visser pj. Neuroimage. 2004 Oct;23(2):708-16. doi: 10.1016/j.neuroimage.2004.07.006. Neuroimage. 2004. PMID: 15488420 Clinical Trial.

10

Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.

Rasquin SM, Lodder J, Visser PJ, Lousberg R, Verhey FR. Rasquin SM, et al. Among authors: visser pj. Dement Geriatr Cogn Disord. 2005;19(2-3):113-9. doi: 10.1159/000082662. Epub 2004 Dec 9. Dement Geriatr Cogn Disord. 2005. PMID: 15591801 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

362 results

Search Page